QUIPT HOME MEDICAL CORP (QIPT) Forecast, Price Target & Analyst Ratings

NASDAQ:QIPTCA74880P1045

Current stock price

3.65 USD
0 (0%)
At close:
3.64 USD
-0.01 (-0.27%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for QUIPT HOME MEDICAL CORP (QIPT).

Forecast Snapshot

Consensus Price Target

Price Target
$3.97
+ 8.74% Upside

Next Earnings Forecast

Earnings Estimate
Release Date
May 11, 2026
Period
Q2 / 2026
EPS Estimate
-$0.13
Revenue Estimate
77.418M

ChartMill Buy Consensus

Rating
76.36%
Weighted Analyst Rating Score

Price Target Details & History

Consensus Price Target and Range

Mean target
$3.97
Upside
+ 8.74%
From current price of $3.65 to mean target of $3.97, Based on 11 analyst forecasts
Low
$3.31
Median
$3.79
High
$4.97

Price Target Revisions

1 Month
-0.38%
3 Months
6.26%

Price Target Summary

11 Wall Street analysts provided a forecast for the next 12 months for QIPT. The average price target is 3.97 USD. This implies a price increase of 8.74% is expected in the next year compared to the current price of 3.65.
The average price target has been revised upward by 6.26% in the past 3 months.

Analyst Ratings & History

Current Analyst Ratings

QIPT Current Analyst RatingQIPT Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4 5

Analyst Ratings History

QIPT Historical Analyst RatingsQIPT Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6 8 10

Analyst Ratings Consensus

ChartMill Buy Consensus
76.36%
QIPT was analyzed by 11 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about QIPT.
In the previous month the buy percentage consensus was at a similar level.
QIPT was analyzed by 11 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-12-17Canaccord GenuityMaintains Hold -> Hold
2025-08-19Canaccord GenuityMaintains Hold -> Hold
2025-05-14BenchmarkMaintains Buy -> Buy
2025-05-13Canaccord GenuityDowngrade Buy -> Hold
2024-08-21BenchmarkMaintains Buy -> Buy
2024-08-16Canaccord GenuityMaintains Buy -> Buy
2024-05-20BenchmarkMaintains Buy -> Buy
2024-05-17Canaccord GenuityMaintains Buy -> Buy
2024-02-16Raymond JamesDowngrade Outperform -> Market Perform
2023-12-20BenchmarkReiterate Buy -> Buy
2023-05-17BenchmarkReiterate Buy -> Buy
2023-02-15BenchmarkReiterate Buy
2023-02-13BenchmarkReiterate Buy
2021-10-20BenchmarkInitiate Buy
2021-06-02Raymond James FinancialInitiate Outperform

Next Earnings Forecast Details

Next Earnings Details

Release Date
May 11, 2026
Period
Q2 / 2026
EPS Estimate
-$0.13
Revenue Estimate
77.418M
Revenue Q2Q
34.93%
EPS Q2Q
-89.43%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
-0.80%
Revenue (3 Months)
-0.75%
EPS (1 Month)
-136.36%
EPS (3 Months)
-420.00%

Next Earnings Summary

QIPT is expected to report earnings on 5/11/2026. The consensus EPS estimate for the next earnings is -0.13 USD and the consensus revenue estimate is 77.42M USD.
The next earnings revenue estimate has been revised downward by 0.75% in the past 3 months.

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
QIPT revenue by date.QIPT revenue by date.
221.7M
58.47%
245.915M
10.92%
245.359M
-0.23%
314.8M
28.30%
320.42M
1.79%
581.09M
81.35%
EBITDA
YoY % growth
QIPT ebitda by date.QIPT ebitda by date.
45.26M
58.03%
45.99M
1.61%
41.251M
-10.30%
66.854M
62.07%
72.456M
8.38%
136.58M
88.50%
EBIT
YoY % growth
QIPT ebit by date.QIPT ebit by date.
5.1M
-8.93%
1.409M
-72.37%
-4.231M
-400.28%
1.101M
126.02%
-1.836M
-266.76%
87.471M
4,864.22%
Operating Margin
QIPT operating margin by date.QIPT operating margin by date.
2.30%0.57%-1.72%0.35%-0.57%15.05%
EPS
YoY % growth
QIPT eps by date.QIPT eps by date.
-0.07
-153.85%
-0.12
-71.43%
-0.25
-108.33%
-0.18
28.60%
-0.29
-60.00%
1.60
658.71%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.13
-89.43%
-0.04
41.71%
0.02
131.24%
Revenue
Q2Q % growth
77.418M
34.93%
78.938M
35.43%
79.963M
17.05%
EBITDA
Q2Q % growth
16.626M
-22.34%
17.065M
-45.02%
17.585M
-60.31%
EBIT
Q2Q % growth
-3.049M
-217.91%
368.73K
114.35%
1.03M
187.21%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

QIPT Yearly Revenue VS EstimatesQIPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M 500M
QIPT Yearly EPS VS EstimatesQIPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 1 -1 -2

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
103.14%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
33.45%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
250.64%
EBIT Next 5 Year
N/A

QUIPT HOME MEDICAL CORP / QIPT Forecast FAQ

Can you provide the average price target for QUIPT HOME MEDICAL CORP stock?

11 analysts have analysed QIPT and the average price target is 3.97 USD. This implies a price increase of 8.74% is expected in the next year compared to the current price of 3.65.

Can you provide the upcoming earnings date for QUIPT HOME MEDICAL CORP?

QUIPT HOME MEDICAL CORP (QIPT) will report earnings on 2026-05-11.

Can you provide the consensus estimates for QUIPT HOME MEDICAL CORP next earnings?

The consensus EPS estimate for the next earnings of QUIPT HOME MEDICAL CORP (QIPT) is -0.13 USD and the consensus revenue estimate is 77.42M USD.

What is the consensus rating for QIPT stock?

The consensus rating for QUIPT HOME MEDICAL CORP (QIPT) is 76.3636 / 100 . This indicates that analysts generally have a positive outlook on the stock.